Home
>
National Drug Code (NDC)
>
MESNEX
MESNEX - 67108-3565-9 - (MESNA)
Drug Information of MESNEX
| Product NDC: | 67108-3565 |
| Proprietary Name: | MESNEX |
| Non Proprietary Name: | MESNA |
| Active Ingredient(s): | 400 mg/1 & nbsp; MESNA |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MESNEX
| Product NDC: | 67108-3565 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020855 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020321 |
Package Information of MESNEX
| Package NDC: | 67108-3565-9 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (67108-3565-9) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Information of MESNEX
| NDC Code | 67108-3565-9 |
| Proprietary Name | MESNEX |
| Package Description | 1 BLISTER PACK in 1 CARTON (67108-3565-9) > 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Product NDC | 67108-3565 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MESNA |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020321 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MESNA |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cytoprotective Agent [EPC] |
